Following the departure of one analyst, we terminate the coverage with recommendation of the following issuers: Advanz Pharma, CBR Fashion Group, Ceconomy, Cheplapharm, Eurofins, Grenke, Grünenthal, IHO/Schaeffler, Ontex, Profine, Progroup, Stada, Teleperformance, Wepa and ZF Friedrichshafen. We intend to gradually resume coverage of some of these companies. Previous credit opinions and market recommendations are listed in the table on page 2.
Following the departure of one analyst, we terminate the coverage with recommendation of the following issuers: Advanz Pharma, CBR Fashion Group, Ceconomy, Cheplapharm, Eurofins, Grenke, Grünenthal, IHO/Schaeffler, Ontex, Profine, Progroup, Stada, Teleperformance, Wepa and ZF Friedrichshafen. We intend to gradually resume coverage of some of these companies. Previous credit opinions and market recommendations are listed in the table on page 2.
Carrefour: Saadé family acquires stake, Peninsula exits|Emeria: an equity fundraising to enable bond refinancing?|Advanz Q3 25 results: Adj. EBITDA drops yoy and net leverage increases further – but not surprising|grenke Q3 25 results: Good operational performance YTD, but loss rate and NPLs increase|Finnair: no surprises on the FY 2026-2029 targets at first sight|
Carrefour : entrée de la famille Saadé au capital et sortie de Peninsula|Emeria : une levée d’equity pour permettre le refinancement des obligations ?|Advanz Q3 25 results: Adj. EBITDA drops yoy and net leverage increases further – but not surprising|grenke Q3 25 results: Good operational performance YTD, but loss rate and NPLs increase|Finnair: no surprises on the FY 2026-2029 targets at first sight|
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.